AACR Project GENIE® is governed by a Steering Committee, which includes representatives from each participating institution and AACR leadership, oversees the strategic direction of the initiative. The Executive Committee, a rotating smaller subset of the Steering Committee, makes time-sensitive decisions.
Steering Committee Members
The Steering Committee includes representatives from each participating institution who play a key role in guiding project strategy and implementation.
*Executive Committee Member
+Executive/Steering Committee Ex Officio Members
Kenneth L. Kehl, MD, MPH*
Chairperson 2025-2026
Associate Director of Clinical Research
Assistant Professor of Medicine, Harvard Medical School
Dana-Farber Cancer Institute
James F. Amatruda, MD, PhD
Interim Chief and Interim Director, Cancer and Blood Disease Institute
Head, Basic and Translational Research
Cancer and Blood Disease Institute
Dr. Kenneth O. Williams Chair in Cancer Research
Children’s Hospital Los Angeles
Professor of Pediatrics and Medicine
Keck School of Medicine of USC
Alexander Baras, MD, PhD*
Director, Pathology Informatics
Associate Professor of Pathology
Johns Hopkins School of Medicine
Philippe Bedard, MD, FRCPC*
Chairperson (2021–2024)v
Associate Professor of Medicine
University of Toronto
Brady Bernard, PhD
Director of Informatics
Providence Cancer Institute
Associate Member of Computational Immuno-oncology
Earle A. Chiles Research Institute
Marcia Cruz-Correa, MD, PhD, AGAF, FASGE*
Chief Medical Officer, PanOncology Trials
Oncology Clinical Research Leader
Professor
UPR Medical Sciences
Christina Curtis, PhD*
Professor of Medicine, Genetics, and Biomedical Data Science
Stanford University
Rodrigo Dienstmann, MD*
Group Leader, Oncology Data Science (ODysSey) Group, VHIO
Research Scientist, Computational Oncology Group, Sage Bionetworks
Vall d’Hebron Institute of Oncology
Margaret Foti, PhD, MD (hc)*
Chief Executive Officer
American Association for Cancer Research®
Kevin Haigis, PhD*
Chief Scientific Officer
Dana-Farber Cancer Institute
Brian Henick, MD
Director of Translational Research
Columbia University
Maud Kamal, PhD
Executive Director Institut Hospitalo Universitaire
PRISM National PRecISion Medicine Center in Oncology
Gustave Roussy Cancer Campus
Marilyn Li, MD*
Vice Chief, Division of Genomic Diagnostics
Director, Cancer Genomic Diagnostics
Children’s Hospital of Philadelphia
Charles L. Sawyers, MD*
Founding Chairperson (2015–2020)
Chair, Human Oncology and Pathogenesis Program
Marie-Josée and Henry R. Kravis Chair
Shannon Jones McCall, MD
Associate Professor of Pathology
Duke University
Gerrit Meijer, MD, PhD
Professor of Oncologic Pathology
Netherlands Cancer Institute
Christine Micheel, PhD*
Research Assistant Professor of Medicine
Division of Hematology/Oncology
Vanderbilt University Medical Center
Lucio Miele, MD, PhD
Professor and Head, Department of Genetics
Senior Associate Dean of Research, LSU Health Sciences Center School of Medicine
Cancer Crusaders Endowed Professor in Cancer Research
The Louisiana State University Health Sciences Center
Kyong Hwa Park (박경화)
Department of Medical Oncology and Hematology
Korea University Anam Hospital
Nikolaus Schultz, PhD+
Memorial Sloan Kettering (cBioPortal)
Stephan Schürer PhD
Professor of Pharmacology
Associate Director of Data Science
Sylvester Comprehensive Cancer Center Director of Digital Drug Discovery
Frost Institute for Data Science & Computing, University of Miami
Alejandro Sweet-Cordero, MD
Professor of Pediatrics
University of California, San Francisco
Adam Taylor, PhD+
Director, Cancer Biology
Sage Bionetworks
Robert H. Vonderheide, MD, DPhil,
Director of the Abramson Cancer Center
Vice Dean for Cancer Programs
University of Pennsylvania’s Perelman School of Medicine
Zenta Walther, MD, PhD*
Clinical Director at YNHH Tumor Profiling Laboratory
Director of Molecular Genetic Pathology Fellowship Program
Yale School of Medicine
Peng Wang, MD, PhD
Professor of Molecular Genetics and Surgical Pathology
University of Chicago